NLS Pharmaceutics Announces the Submission of Three Research Abstracts to the 2025 ASCP ...
NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system ...
United Therapeutics president sells shares worth $3.7 million
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock ...
Centessa Pharmaceuticals chief business officer sells shares worth $193,429
Gregory M. Weinhoff, the Chief Business Officer of Centessa Pharmaceuticals plc (NASDAQ:CNTA), a $2.16 billion market cap ...
NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the ...
NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...